STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
NCT01810874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2015-04-29
Summary
The purpose of this study is to determine whether the extraperitoneal approach is better than the transperitoneal approach for laparoscopic aortic lymphadenectomy for the surgical staging of endometrial or ovarian cancer.
Conditions
- Endometrial Neoplasms
- Ovarian Neoplasms
Interventions
- PROCEDURE
-
Transperitoneal laparoscopic aortic lymphadenectomy
Aortic/para-aortic lymph nodes dissection and retrieval by transperitoneal laparoscopy; the intervention may be completed by robotic-assisted or traditional laparoscopy.
- PROCEDURE
-
Extraperitoneal laparoscopic aortic lymphadenectomy
Aortic/para-aortic lymph nodes dissection and retrieval by extraperitoneal laparoscopy; the intervention may be completed by robotic-assisted or traditional laparoscopy.
Sponsors & Collaborators
-
Fundación Mutua Madrileña
collaborator OTHER -
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Principal Investigators
-
Antonio Gil Moreno, M.D., PhD · Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
-
Berta Díaz Feijoo, M.D., PhD · Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
-
Jose Luis Sánchez, M.D. · Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
-
Alejandro Correa Paris, M.D. · Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
-
M. Assumpció Pérez-Benavente, M.D., PhD · Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
-
Silvia Cabrera Díaz, M.D. · Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
-
Silvia Franco Camps, M.D. · Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
-
Oriol Puig Puig, M.D. · Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
Study Design
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2014-07-31
- Completion
- 2015-04-30
Countries
- Spain
More Related Trials
-
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT00055614 ·Status: COMPLETED ·Phase: PHASE1
-
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT01670799 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
NCT06240598 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
NCT03624712 ·Status: RECRUITING
-
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
NCT01244789 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Improving the Treatment for Women With Early Stage Cancer of the Uterus
NCT01686126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer
NCT03754569 ·Status: COMPLETED ·Phase: NA
-
S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
NCT00003120 ·Status: COMPLETED ·Phase: PHASE3
-
Platine, Avastin and OLAparib in 1st Line
NCT02477644 ·Status: COMPLETED ·Phase: PHASE3
-
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
NCT01218490 ·Status: SUSPENDED ·Phase: PHASE3
-
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00021034 ·Status: COMPLETED ·Phase: PHASE1
-
Sentinel Node Biopsy in Endometrial Cancer
NCT04073706 ·Status: RECRUITING ·Phase: PHASE3
-
Pretherapeutic Paraaortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Versus Definitive Chemoradiotherapy
NCT02848716 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
NCT02489006 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers
NCT05186493 ·Status: RECRUITING ·Phase: NA
-
Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy
NCT04415944 ·Status: COMPLETED ·Phase: PHASE2
-
Lymphadenectomy In Ovarian Neoplasms
NCT00712218 ·Status: COMPLETED ·Phase: NA
-
Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00287859 ·Status: TERMINATED ·Phase: PHASE1
-
Comparison of Nodal Staging in Endometrial Cancer
NCT04970368 ·Status: TERMINATED ·Phase: PHASE3
-
Debulking Surgery in Ovarian Cancer
NCT03378128 ·Status: COMPLETED ·Phase: NA
-
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
NCT01137071 ·Status: TERMINATED ·Phase: PHASE2
-
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
NCT02249013 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients
NCT01905163 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Long-Term Responders on Olaparib
NCT02489058 ·Status: COMPLETED
-
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
NCT03748186 ·Status: COMPLETED ·Phase: PHASE1